Urinary exosomal microRNAs as predictors of acute kidney injury severity in critical care patients

Abstract

Acute kidney injury (AKI) is a complication of initial disease whose impact is gigantic and is predominantly lethal. Recuperation depends on not allowing additional harm, prompt diagnosis of the disease and evaluation of its severity. In this article, the prognostic role of urine exosomal microRNAs in AKI se verity prediction in critically ill patients is examined. These are people for whom early diagnosis of AKI becomes necessary. AKI patients with exosome-rich urine were discussed and the microRNAs that make
up certain were quantified and described. These microRNAs were selected based on possible causations of renal damage and involvement in renal function. The findings indicate a strong correlation between certain microRNAs and AKI severity. This shows the predictive potential of those molecules for renal damage and dysfunction. The presence of exosomal microRNAs in urine can predict AKI in a non-invasive manner, thus providing a rightful alternative to traditional methods that are more invasive and complicated. The implications of this study suggest that the use of microRNAs in practice can lead to an accurate diagnosis.
Furthermore, biomarkers can enhance patient-centered care by tailoring the severity of treatment to the degree of renal failure. Since it is a non-surgical method, it can minimize the number of repeat invasive treatments the patient must undergo, which enhances comfort while also reducing healthcare costs.
Further research is necessary to investigate the role of exosomal microRNAs in the context of AKI and to determine the long-term therapeutic benefits, beyond the current preliminary data, in larger, more diverse populations to confirm the results presented here.